Literature DB >> 21508045

Gilbert's syndrome.

Lee C Claridge1, Matthew J Armstrong, Caroline Booth, Paramjit S Gill.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21508045     DOI： 10.1136/bmj.d2293

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  7 in total

Review 1.  Gilbert syndrome.

Authors:  Andrew Fretzayas; Maria Moustaki; Olga Liapi; Themistocles Karpathios
Journal:  Eur J Pediatr       Date:  2011-12-09       Impact factor: 3.183

2.  Gilbert Syndrome and Genetic Findings in Children: A Tertiary-Center Experience from Turkey.

Authors:  Yeliz Çağan Appak; Betül Aksoy; Berk Özyılmaz; Taha Reşid Özdemir; Maşallah Baran
Journal:  Turk Arch Pediatr       Date:  2022-05

3.  Evaluating elevated bilirubin levels in asymptomatic adults.

Authors:  Lisa B VanWagner; Richard M Green
Journal:  JAMA       Date:  2015-02-03       Impact factor: 56.272

4.  Diagnosis and treatment of a 16-year-old Chinese patient with concurrent hereditary hemochromatosis and Gilbert's syndrome.

Authors:  Xianbo Wang; Yanmin Liu; Yujuan Chang; Huimin Liu; Peng Wang
Journal:  Eur J Med Res       Date:  2014-09-28       Impact factor: 2.175

5.  "Gilbert's-like" syndrome as part of a spectrum of persistent unconjugated hyperbilirubinemia in post-chronic hepatitis patients.

Authors:  Jin Ye; Lianlian Cui; Yingqiao Zhou; Ying Huang; Omar Banafa; Xiaohua Hou; Zhen Ding; Rong Lin
Journal:  Sci Rep       Date:  2018-01-31       Impact factor: 4.379

Review 6.  Consensus guidelines: best practices for detection, assessment and management of suspected acute drug-induced liver injury occurring during clinical trials in adults with chronic cholestatic liver disease.

Authors:  Melissa Palmer; Arie Regev; Keith Lindor; Mark I Avigan; Lara Dimick-Santos; William Treem; John F Marcinak; James H Lewis; Frank A Anania; Daniel Seekins; Benjamin L Shneider; Naga Chalasani
Journal:  Aliment Pharmacol Ther       Date:  2019-11-25       Impact factor: 8.171

7.  Determining the validity of hospital laboratory reference intervals for healthy young adults participating in early clinical trials of candidate vaccines.

Authors:  Rosalind Rowland; Geraldine A O'Hara; Matthew Hamill; Ian D Poulton; Hannah Donaldson; Laura Dinsmore; Timothy James; Eleanor Barnes; Paul Klenerman; Sarah C Gilbert; Adrian V S Hill; Brian Shine; Helen McShane
Journal:  Hum Vaccin Immunother       Date:  2013-06-03       Impact factor: 3.452
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.